Overview
This course provides nursing professionals with an overview of stroke management in the acute care setting.Goals and Learning Outcomes
This course offers a comprehensive overview of managing stroke during the critical phase, from stabilizing the patient to hospital discharge. It covers the two main types of strokes, ischemic and hemorrhagic, and their respective treatments. This course also focuses on the outcomes of stroke and how nurse management can improve outcomes and prevent complications from stroke.
- Identify signs, symptoms, and complications of acute stroke.
- Apply best practices for the management of stroke in the acute phase.
- Recall factors that influence stroke outcome and the risk for complications.
Course Details
Course Originally Released on : 12/1/2024
REL-ACU-0-TOASTR
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.